Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma
F. Bertolini et al., Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma, LEUKEMIA, 14(8), 2000, pp. 1477-1482
Recent reports suggest that green tea consumption may prevent or delay the
growth of human cancer, possibly by impairing tumor invasion and/or by an a
nti-angiogenic effect. In NOD/SCID mice transplanted intraperitoneally with
human non-Hodgkin's lymphoma (NHL) cell lines, Namalwa, RAP1-EIO and MS-Su
ltan, green tea prevented 50% of Namalwa tumors (P = 0.0017 by log-rank) an
d significantly inhibited RAP1-EIO and HS-Sultan tumor growth. Notably, tre
atment with the chemotherapy drug cyclophosphamide at the maximum tolerable
dose was unable to prevent Namalwa tumor occurrence. In the three models e
valuated, the frequency of apoptotic endothelial and tumor cells was signif
icantly increased in mice given green tea compared to controls. These resul
ts support further trials in NHL to evaluate whether green tea, alone or in
combination with chemotherapy, may delay or prevent disease progression.